{
    "url_original": "https://www.wsj.com/articles/pfizer-says-its-covid-19-pill-likely-works-against-omicron-11639482302?mod=business_lead_pos1",
    "url": "pfizer-says-its-covid-19-pill-likely-works-against-omicron-11639482302",
    "title": "Pfizer Says Its Covid-19 Pill Likely Works Against Omicron",
    "sub_head": "Antiviral drug Paxlovid stayed 89% effective at reducing the risk of hospitalization and death in a final analysis of a key study in high-risk adults",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-12-14 06:45:00",
    "body": "Preliminary laboratory tests gave encouraging signs that  Pfizer Inc.â€™s  experimental Covid-19 pill for the newly infected could work against Omicron, the company said.<br />Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective at reducing the risk of hospitalization and death in adults at high risk of severe Covid-19."
}